ZYDUSLIFENSEZydus Lifesciences Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Thu, 17 Apr, 2025 · 15:35 IST

Zydus Lifesciences Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

ZYDUSLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.8%Reaction day
₹830.90
prior close
₹832.35
announcement price
After-mkt
timing
Nifty 100market · index membership as recorded later (tracked since Jun 2026)+1.3%+0.5% vs market
Pharmaceuticals peers, median of 148sector+0.6%+1.1% vs sector

On the reaction day the stock moved 0.5 pts more than Nifty 100 and 1.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
+0.2
15m
+0.1
30m
+0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.8+1.3+0.5+0.6+1.1
Next day
+2.5+1.4+1.0+0.9+1.6
2d
+4.4+2.1+2.2+1.6+2.8
3d
+5.9+1.8+4.1+2.8+3.1
4d
+3.3+0.7+2.7-0.8+4.1
5d
+6.5+1.9+4.7-0.9+7.4
1w
+6.6+1.7+4.8-2.6+9.1
15d
+8.4+2.7+5.7-0.2+8.6
1m
+7.1+4.1+3.1+2.5+4.6
2m
+14.7+4.6+10.1+0.5+14.2
3m
+16.7+5.4+11.2+7.5+9.2
UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 148Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zydus Lifesciences has informed the stock exchange about a pending litigation or dispute, or the outcome of one, that may impact the company. The specific nature, financial quantum, counterparty, or forum of the dispute is not detailed in the headline provided. No timeline or expected resolution date has been disclosed. Shareholders would need to refer to the full filing on the NSE/BSE website for granular details. The disclosure itself is a routine regulatory compliance requirement under SEBI listing obligations.

Likely market impact

Neutral to mildly negative in tone, as any litigation disclosure can create short-term uncertainty, but the lack of specifics means there is no clear catalyst for a price move until more details emerge.